U.S. Pharmacist Vaccine Update
March 28, 2019

Early or Late Flu Vaccination: Which Is Better for Seniors?
Here is a difficult question: Should older people get influenza vaccinations in October so protection doesn’t wane before the season ends or receive shots as soon as those are available in August, in case flu comes early? A new study analyzed the situation and came up with the following verdict: It depends. Here are the details.

Large Study Confirms That MMR Vaccination Doesn’t Increase Autism Risk
A Danish study confirms past research refuting any link between the mumps, measles, and rubella vaccine and increased risk of autism in children. In fact, it didn’t even find a relationship when children were already at  heightened risk. Here is more information on data pharmacists can provide to concerned parents.

New Recombinant Zoster Vaccine to Prevent Shingles Deemed Cost-Effective
A CDC-funded study has concluded that the recombinant zoster vaccine (RZV) is more cost-effective than the live attenuated vaccine when it comes to herpes zoster prevention. Find out how researchers came to that conclusion and how cost-effective RZV was determined to be, especially for people age 60 years and older.


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App